Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower net loss.
Rite Aid Corporation (RAD) Q4 2023 net loss narrows
Categories
Health Care
Ocean Biomedical co-founder Jack Elias to receive US patent for pulmonary fibrosis treatments
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and commercializing their
Abbott Laboratories (ABT) Q1 2023 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Intuitive Surgical (ISRG) looks poised for a strong year ahead
The healthcare industry has been witnessing an increase in demand for robotic-assisted surgical procedures due to their high efficiency and convenience. Intuitive
Intuitive Surgical (ISRG) Q1 adj. profit and revenue increase
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2023, reporting higher revenues and adjusted
Infographic: Highlights of Abbott Laboratories’ Q1 2023 results
Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net sales and
Intuitive Surgical, Inc. (ISRG) Q1 2023 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations Gary
Intuitive Surgical Inc (ISRG) Q1 2023 Earnings Call Transcript
Intuitive Surgical Inc (NASDAQ:ISRG) Q1 2023 Earnings Call dated Apr. 18, 2023. Corporate Participants: Brian King -- Treasurer and Head of Investor Relations Gary
Johnson & Johnson (JNJ) Q1 2023 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joseph J.
JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2023 earnings results today. Reported sales increased 5.6% year-over-year to $24.7 billion. On a
The future looks bright for UnitedHealth Group (UNH). Is the stock a buy?
Health insurance companies have been witnessing a decline in claims lately as non-urgent medical procedures are being deferred due to high inflation
Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing their discoveries,
UnitedHealth Group Incorporated (UNH) Q1 2023 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q1 2023 earnings call dated Apr. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- President and
UnitedHealth Group (UNH) Earnings: 1Q23 Key Numbers
UnitedHealth Group (NYSE: UNH) reported first quarter 2023 earnings results today. Revenues grew 15% year-over-year to $92 billion, helped by double-digit growth
Ocean Biomedical gets Notice of Allowance for US patent application for developing new malaria therapeutics
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing their discoveries,
What to expect when UnitedHealth Group (UNH) reports Q1 2023 earnings
Shares of UnitedHealth Group Inc. (NYSE: UNH) stayed green on Wednesday. The stock has gained nearly 6% over the past three months.
Organigram Holdings, Inc (OGI) Q2 2023 Earnings Call Transcript
Organigram Holdings, Inc. (NASDAQ: OGI) Q2 2023 earnings call dated Apr. 12, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations Beena Goldenberg -- Chief
Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a platform to
Key factors to consider before investing in Abbott Laboratories (ABT)
Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues benefitted from
Ocean Biomedical (OCEA) announces new findings in relation to treatment options for Hermansky-Pudlak Syndrome
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) announced its commitment to developing viable treatment options for Hermansky-Pudlak Syndrome (HPS) on Thursday. The
CVS Health Corporation (CVS) bets big on primary care. What future holds
Retail pharmacy chain CVS Health Corporation (NYSE: CVS) has been diversifying with the aim of tapping into emerging opportunities, while also aligning